-
Patricia Fernandez
Experimental Ophthalmology Laboratory, Clinica Universidad de Navarra, Pamplona, Spain
IdiSNA, Pamplona, Spain
-
Sergio Recalde
Experimental Ophthalmology Laboratory, Clinica Universidad de Navarra, Pamplona, Spain
IdiSNA, Pamplona, Spain
-
Maria Hernandez
Experimental Ophthalmology Laboratory, Clinica Universidad de Navarra, Pamplona, Spain
IdiSNA, Pamplona, Spain
-
Laura Garcia-Garcia
Experimental Ophthalmology Laboratory, Clinica Universidad de Navarra, Pamplona, Spain
-
Jaione Bezunartea
Experimental Ophthalmology Laboratory, Clinica Universidad de Navarra, Pamplona, Spain
-
Juan Roberto Rodriguez
Cell Therapy Area. Division of Cancer., Center for Applied Medical Research (CIMA), Pamplona, Spain
-
Corinne Marie
Unité de Technologies Chimiques et Biologiques pour la Santé, INSERM U1022 – CNRS UMR8258, Paris, France
-
Daniel Scherman
Unité de Technologies Chimiques et Biologiques pour la Santé, INSERM U1022 – CNRS UMR8258, Paris, France
-
Zsuzsanna Izsvak
Max Delbrück Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany
-
Martina Kropp
Experimental Ophthalmology, University of Geneva, Geneva, Switzerland
Department of Ophthalmology, University Hospitals of Geneva, Geneva, Switzerland
-
Sandra Johnen
RWTH Aachen University, Aachen, Germany
-
Gabriele Thumann
Experimental Ophthalmology, University of Geneva, Geneva, Switzerland
Department of Ophthalmology, University Hospitals of Geneva, Geneva, Switzerland
-
Alfredo García-Layana
Experimental Ophthalmology Laboratory, Clinica Universidad de Navarra, Pamplona, Spain
IdiSNA, Pamplona, Spain